Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Safety and efficacy of off-label bulevirtide monotherapy in patients with HDV with decompensated Child-B cirrhosis-A real-world case series.

  • Authors : Dietz-Fricke C; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.; Degasperi E

Subjects: Liver Cirrhosis*/Liver Cirrhosis*/Liver Cirrhosis*/drug therapy ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/adverse effects

  • Source: Hepatology (Baltimore, Md.) [Hepatology] 2024 Sep 01; Vol. 80 (3), pp. 664-673. Date of Electronic Publication: 2024 Mar 13.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Clinical trials in hepatitis D virus: Measuring success.

  • Authors : Da BL; Division of Hepatology, Department of Internal Medicine, Sandra Atlas Bass Center for Liver Diseases and Transplantation , Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Health , Manhasset , New York , USA.

Subjects: Hepatitis D* ; Hepatitis D, Chronic*/Hepatitis D, Chronic*/Hepatitis D, Chronic*/drug therapy; Humans

  • Source: Hepatology (Baltimore, Md.) [Hepatology] 2023 Jun 01; Vol. 77 (6), pp. 2147-2157. Date of Electronic Publication: 2022 Oct 22.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Treatment of chronic hepatitis D with peginterferon lambda-the phase 2 LIMT-1 clinical trial.

  • Authors : Etzion O; Department of Gastroenterology and Liver Diseases, Soroka University Medical Center, Beer-Sheva, Israel.; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/adverse effects ; Hepatitis D, Chronic*/Hepatitis D, Chronic*/Hepatitis D, Chronic*/drug therapy; Humans

  • Source: Hepatology (Baltimore, Md.) [Hepatology] 2023 Jun 01; Vol. 77 (6), pp. 2093-2103. Date of Electronic Publication: 2023 Feb 20.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Association of hepatitis delta virus with liver morbidity and mortality: A systematic literature review and meta-analysis.

  • Authors : Gish RG; University of Nevada, Reno School of Medicine, Kirk Kerkorian School of Medicine at UNLV, Las Vegas, USA.; Wong RJ

Subjects: Hepatitis Delta Virus*/Hepatitis Delta Virus*/Hepatitis Delta Virus*/genetics; Humans ; Disease Progression

  • Source: Hepatology (Baltimore, Md.) [Hepatology] 2024 May 01; Vol. 79 (5), pp. 1129-1140. Date of Electronic Publication: 2023 Oct 23.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis.

  • Authors : Yurdaydin C; Department of GastroenterologyUniversity of Ankara Medical SchoolAnkaraTurkey.; Hepatology InstituteUniversity of AnkaraAnkaraTurkey.

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/drug therapy ; Hepatitis D, Chronic*/Hepatitis D, Chronic*/Hepatitis D, Chronic*/drug therapy; Alanine Transaminase

  • Source: Hepatology (Baltimore, Md.) [Hepatology] 2022 Jun; Vol. 75 (6), pp. 1551-1565. Date of Electronic Publication: 2021 Dec 23.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Endpoints and New Options for Treatment of Chronic Hepatitis D.

  • Authors : Lok AS; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI.; Negro F

Subjects: Hepatitis D, Chronic/Hepatitis D, Chronic/Hepatitis D, Chronic/*therapy; Antiviral Agents/Antiviral Agents/Antiviral Agents/therapeutic use ; Biomarkers

  • Source: Hepatology (Baltimore, Md.) [Hepatology] 2021 Dec; Vol. 74 (6), pp. 3479-3485. Date of Electronic Publication: 2021 Sep 16.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Editorial & Opinion

Letter to the Editor: Interferon Is Not an Optimal Treatment for Chronic Hepatitis Delta but Needs "Fair Treatment" by Us.

  • Authors : Keskin O; Faculty of MedicineDepartment of GastroenterologyHacettepe UniversityAnkaraTurkey.; Yurdaydin C

Subjects: Hepatitis D, Chronic* ; Interferons*; Antiviral Agents/Antiviral Agents/Antiviral Agents/adverse effects

  • Source: Hepatology (Baltimore, Md.) [Hepatology] 2021 Aug; Vol. 74 (2), pp. 1127.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Preliminary Evidence for Hepatitis Delta Virus Exposure in Patients Who Are Apparently Not Infected With Hepatitis B Virus.

  • Authors : Chemin I; Cancer Research Center of LyonUMR Inserm 1052 - CNRS 5286 mixte CLB - UCBL1LyonFrance.; Pujol FH

Subjects: Hepatitis C, Chronic/Hepatitis C, Chronic/Hepatitis C, Chronic/*epidemiology ; Hepatitis D, Chronic/Hepatitis D, Chronic/Hepatitis D, Chronic/*epidemiology ; Hepatitis Delta Virus/Hepatitis Delta Virus/Hepatitis Delta Virus/*isolation & purification

  • Source: Hepatology (Baltimore, Md.) [Hepatology] 2021 Feb; Vol. 73 (2), pp. 861-864. Date of Electronic Publication: 2021 Jan 27.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Spontaneous Clearance of Chronic Delta Hepatitis.

  • Authors : Kapuria D; Liver Disease Branch, National Institutes of Health, Bethesda, MD.; Department of Gastroenterology, University of New Mexico, Albuquerque, NM.

Subjects: Remission, Spontaneous*; Alanine Transaminase/Alanine Transaminase/Alanine Transaminase/*blood ; Hepatitis D, Chronic/Hepatitis D, Chronic/Hepatitis D, Chronic/*enzymology

  • Source: Hepatology (Baltimore, Md.) [Hepatology] 2020 May; Vol. 71 (5), pp. 1873-1875.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta.

Subjects: Hepatitis D, Chronic/Hepatitis D, Chronic/Hepatitis D, Chronic/*drug therapy ; Hepatitis D, Chronic/Hepatitis D, Chronic/Hepatitis D, Chronic/*virology ; Hepatitis Delta Virus/Hepatitis Delta Virus/Hepatitis Delta Virus/*genetics

  • Source: Hepatology (Baltimore, Md.) [Hepatology] 2014 Jul; Vol. 60 (1), pp. 87-97.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  21 results for ""Hepatitis D, Chronic""